Codexis (NASDAQ:CDXS) Receives “Overweight” Rating from Cantor Fitzgerald
Cantor Fitzgerald restated their overweight rating on shares of Codexis (NASDAQ:CDXS – Free Report) in a research note released on Friday,Benzinga reports. They currently have a $11.00 price target on the biotechnology company’s stock. Separately, Benchmark reaffirmed a “hold” rating on shares of Codexis in a research note on Monday, November 4th. Get Our Latest […]
16 Nov 17:46 · The Markets Daily